JLab has been acquired by Noritsu Koki Co., Ltd.
Catalyst Holdings has sold JLab Audio (JLab), a leading personal audio brand, to Japan-based Noritsu Koki Co., Ltd. (TSE:7744) (NKC).
Founded in 2005 and based in Carlsbad, California, JLab is the number one seller of headphones under US$50, the number one seller of true wireless earbuds under US$100 as well as the number one kids’ headphone brand in the US, according to NPD. Driven by its relentless focus on innovation, visionary leadership and unique, accessible brand positioning, the company has experienced rapid growth over the past several years, gaining broad retail distribution in over 20,000 doors for its extensive product portfolio.
Based in Tokyo, Japan, NKC is a diversified holding company whose subsidiaries engage in manufacturing and healthcare activities. In April 2020, Noritsu Koki completed the acquisition of AlphaTheta, which offers professional DJ equipment under several brands, most notable Pioneer DJ.
Catalyst Holdings is a private equity firm that owned a majority stake in JLab.
Oaklins Intrepid in Los Angeles acted as sell-side advisor in this transaction.
Win Cramer
CEO, JLab Audio
Prata med transaktionsteamet
Relaterade affärer
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Lär dig merDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Lär dig merXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Lär dig mer